Keyphrases
Radical Prostatectomy
100%
Equal Access
57%
Cancer Hospital
52%
Prostate Cancer
44%
Hospital Database
44%
Biochemical Recurrence
38%
Prostate-specific Antigen
26%
Metastasis
18%
Prostate
17%
Castration-resistant Prostate Cancer
16%
Transrectal Ultrasound
16%
Hazard Ratio
16%
Prostate Cancer Risk
16%
Obesity
15%
Body Mass Index
13%
Prostate-specific Antigen Level
12%
Confidence Interval
11%
Androgen Deprivation Therapy
11%
Prostate Biopsy
11%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
10%
Positive Surgical Margin
10%
Bladder Cancer
10%
Prostate Cancer Outcomes
10%
Prostate-specific Antigen Doubling Time
9%
Black Men
9%
Overall Survival
8%
Tumor
8%
Active Surveillance
8%
Seminal Vesicle Invasion
7%
Prostate Cancer Screening
7%
All-cause Mortality
7%
Multivariable
7%
Prostate-specific Antigen Recurrence
7%
Gleason Sum
7%
Odds Ratio
6%
Ultrasound-guided
6%
Bone Scan
6%
Sextant
6%
Prostate Cancer Patients
6%
White People
6%
Recurrence Risk
6%
Low Risk
6%
Biochemical Progression
6%
High Risk
5%
Multivariate Analysis
5%
Transperineal Prostate Biopsy
5%
Total Prostate-specific Antigen
5%
PSA Doubling Time
5%
Prostatectomy
5%
Recurrent Disease
5%
Medicine and Dentistry
Prostatectomy
87%
Prostate Cancer
80%
Malignant Neoplasm
61%
Prostate Specific Antigen
47%
Biopsy
41%
Biochemical Recurrence
29%
Metastatic Carcinoma
22%
Transrectal Ultrasonography
20%
Disease
20%
Gleason Score
20%
Prostate Biopsy
19%
Castration Resistant Prostate Cancer
18%
Recurrent Disease
17%
Body Mass Index
15%
Neoplasm
14%
Hazard Ratio
13%
Surgical Margin
12%
Proportional Hazards Model
9%
Seminal Vesicle
8%
Cancer
8%
Overall Survival
8%
Veterans Affairs
7%
Transitional Cell Carcinoma
7%
Bladder
7%
Androgen Deprivation Therapy
6%
Cancer Diagnosis
6%
Clear Cell Renal Cell Carcinoma
6%
Odds Ratio
6%
Logistic Regression Analysis
6%
Clinical Stage
5%
Bone Scintigraphy
5%
All Cause Mortality
5%
Cohort Analysis
5%
Needle Biopsy
5%